AlphaFold 3 Solves Protein-Drug Interaction Problem

Google DeepMind's AlphaFold 3, released in 2024 and widely adopted in 2025, extended protein structure prediction to model interactions between proteins, DNA, RNA, and small-molecule drugs with unprecedented accuracy. The breakthrough accelerated drug discovery timelines from years to months for multiple disease targets. Pharmaceutical companies reported over 200 new drug candidates identified using AlphaFold 3 data within the first year of its release.